Relife Pharmaceuticals Opc Profile
Key Indicators
- Authorised Capital ₹ 9.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 9 Year, 21 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 Cr
- Revenue Growth 19.49%
- Profit Growth 20.65%
- Ebitda 5.15%
- Net Worth 51.84%
- Total Assets -5.53%
About Relife Pharmaceuticals Opc
Relife Pharmaceuticals Opc Private Limited (RPOPL) is a Company incorporated in India on 16 February 2016 (Nine years 21 days old ). Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹5.00 Cr.
Santosh Shah serves as a director at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U52100WB2016OPC209749
- Company No.
209749
- Incorporation Date
16 Feb 2016
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Pharma
What products or services does Relife Pharmaceuticals Opc Private Limited offer?
Relife Pharmaceuticals Opc Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement, Bird Food, Poultry & Animal Food, Animal Feed Supplement, Animal Medicines & Health Care, Veterinary Injections, Fertilizers and Soil Additives, Plant Growth Promoters, Digestive System Drugs & Medicines, Antacid Drugs.
Who are the key members and board of directors at Relife Pharmaceuticals Opc?
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Shah  | Director | 16-Feb-2016 | Current |
Financial Performance of Relife Pharmaceuticals Opc.
Relife Pharmaceuticals Opc Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.49% increase. The company also saw a substantial improvement in profitability, with a 20.65% increase in profit. The company's net worth Soared by an impressive increase of 51.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Relife Pharmaceuticals Opc?
Unlock access to Relife Pharmaceuticals Opc's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
Open Charges
₹50.00 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 5.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 May 2024 | Others | ₹2.50 Cr | Open |
| 28 Dec 2023 | Others | ₹2.50 Cr | Open |
How Many Employees Work at Relife Pharmaceuticals Opc?
Relife Pharmaceuticals Opc has a workforce of 26 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Relife Pharmaceuticals Opc, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Relife Pharmaceuticals Opc's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Relife Pharmaceuticals Opc
Recent activity within the organization
- Charges
A charge with Others amounted to Rs. 25.00 M with Charge ID 100917101 was registered on 10 May 2024.
- Charges
A charge with Others amounted to Rs. 25.00 M with Charge ID 100849182 was registered on 28 Dec 2023.
- Balance Sheet
Relife Pharmaceuticals Opc Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Kolkata.
- Annual General Meeting
Relife Pharmaceuticals Opc Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
- Director Appointment
Santosh Kumar Shah was appointed as a Director was appointed as a Director on 16 Feb 2016 & has been associated with this company since 9 years 21 days .
- Company Incorporation
Relife Pharmaceuticals Opc Private Limited was registered on 16 Feb 2016 with Roc Kolkata & aged 9 years 21 days as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Relife Pharmaceuticals Opc Private Limited?
Relife Pharmaceuticals Opc Private Limited was incorporated on 16 Feb 2016.
What is authorized share capital and paid-up capital of Relife Pharmaceuticals Opc Private Limited?
The authorized share capital of Relife Pharmaceuticals Opc Private Limited is ₹ 9.00 M and paid-up capital is ₹ 5.00 M.
Who are the current board members & directors of Relife Pharmaceuticals Opc Private Limited?
Currently 1 director is associated with Relife Pharmaceuticals Opc Private Limited.
- Santosh Kumar Shah
What is the registered address of Relife Pharmaceuticals Opc Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Relife Pharmaceuticals Opc Private Limited is D3 64/230 Alampur Bye Lane - Ii, Belpukur Road Near Sitala Mandir India, Kolkata, West Bengal, 700024.
What is the corporate identification number (CIN) and company number of Relife Pharmaceuticals Opc Private Limited?
The corporate identification number (CIN) of Relife Pharmaceuticals Opc Private Limited is U52100WB2016OPC209749 and the company number is 209749 as per Ministry of Corporate Affairs (MCA).
What is the official website of Relife Pharmaceuticals Opc Private Limited?
The Official website of Relife Pharmaceuticals Opc Private Limited is https://www.relifepharma.com
What has been the recent revenue trend for Relife Pharmaceuticals Opc Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Relife Pharmaceuticals Opc Private Limited has risen by 19.49%.
How many employees does Relife Pharmaceuticals Opc Private Limited currently have?
As Per 2023 financial reports, 26 employees are currently employed by Relife Pharmaceuticals Opc Private Limited.
What change has been observed in the net worth of Relife Pharmaceuticals Opc Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Relife Pharmaceuticals Opc Private Limited has experienced an upsurge of 51.84%.
What are the total open charges for Relife Pharmaceuticals Opc Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Relife Pharmaceuticals Opc Private Limited amount to ₹ 5.00 Cr.
When was the last Balance Sheet of Relife Pharmaceuticals Opc Private Limited filed with the ROC?
The most recent Balance Sheet for Relife Pharmaceuticals Opc Private Limited was filed with the ROC on 31 Mar 2023.
People also Viewed
AS
Anjana ShawDirector
Similar Companies Based on Animal Pharmaceuticals & Healthcare
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Vadodara, Gujarat, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India